SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-000129
Filing Date
2023-02-14
Accepted
2023-02-14 17:01:29
Documents
57
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20221231x10q.htm   iXBRL 10-Q 1129678
2 EX-31.1 nnvc-20221231xex31d1.htm EX-31.1 12291
3 EX-31.2 nnvc-20221231xex31d2.htm EX-31.2 13667
4 EX-32.1 nnvc-20221231xex32d1.htm EX-32.1 7106
5 EX-32.2 nnvc-20221231xex32d2.htm EX-32.2 7140
  Complete submission text file 0001410578-23-000129.txt   4332005

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20221231.xsd EX-101.SCH 36635
7 EX-101.CAL nnvc-20221231_cal.xml EX-101.CAL 29989
8 EX-101.DEF nnvc-20221231_def.xml EX-101.DEF 144706
9 EX-101.LAB nnvc-20221231_lab.xml EX-101.LAB 290372
10 EX-101.PRE nnvc-20221231_pre.xml EX-101.PRE 214174
51 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20221231x10q_htm.xml XML 620886
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 23631204
SIC: 2834 Pharmaceutical Preparations